ArticleAntiviral research2024

SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.

Kabita Pandey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.